Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease

Autor: Alvise Berti 1, 2, Emanuel Della-Torre 1, Francesca Gallivanone 3, Carla Canevari 4, Raffaella Milani 5, Marco Lanzillotta 1, Corrado Campochiaro 1, Giuseppe Alvise Ramirez 1, Emanuele Bozzalla Cassione 1, Enrica Bozzolo 2, Federica Pedica 6, Isabella Castiglioni 3, Paolo Giorgio Arcidiacono 7, Gianpaolo Balzano 8, Massimo Falconi 2, 4, 8, Luigi Gianolli 5, Lorenzo Dagna 1

Publikováno v: Rheumatology (Sunnyvale, Calif.) 56 (2017): 2084–2092. doi:10.1093/rheumatology/kex234
info:cnr-pdr/source/autori:Alvise Berti 1,2,*, Emanuel Della-Torre 1,2,*, Francesca Gallivanone 3, Carla Canevari 4, Raffaella Milani 5, Marco Lanzillotta 1,2, Corrado Campochiaro 1,2, Giuseppe Alvise Ramirez 1,2, Emanuele Bozzalla Cassione 1,2, Enrica Bozzolo 2, Federica Pedica 6, Isabella Castiglioni 3, Paolo Giorgio Arcidiacono 7, Gianpaolo Balzano 8, Massimo Falconi 2,4,8, Luigi Gianolli 5 and Lorenzo Dagna 1,2/titolo:Quantitative measurement of 18F-FDG PET%2FCT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease/doi:10.1093%2Frheumatology%2Fkex234/rivista:Rheumatology (Sunnyvale, Calif.)/anno:2017/pagina_da:2084/pagina_a:2092/intervallo_pagine:2084–2092/volume:56

Objective. [18F]Fluorodeoxyglucose (18F-FDG) PET/CT is increasingly used to assess organ involvement and response to treatment in IgG4-related disease (IgG4-RD), but clear correlations between 18F-FDG uptake and disease activity have not been establi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::092bc9d21f5cc97d91ca595adcf87ebb
https://pubmed.ncbi.nlm.nih.gov/28977663